Read + Share
Amedeo Smart
Independent Medical Education
Guan D, Shi Q, Zheng Y, Zheng C, et al. Real-World Data on Pathological Response and Survival Outcomes After Neoadjuvant Chemotherapy in HER2-Low Breast Cancer Patients. Clin Breast Cancer 2024 Apr 14:S1526-8209(24)00106.PMID: 38744585
Email
LinkedIn
Privacy Policy